# Anshi Pharmaceutical (Zhongshan) Inc. – FDA Inspection, Oct 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/anshi-pharmaceutical-zhongshan-inc/3bc27a1f-511b-4bbd-8a31-de9c950fc7c7
Source feed: FDA_Inspections

> FDA inspection 1031944 of Anshi Pharmaceutical (Zhongshan) Inc., October 27, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031944
- Company Name: Anshi Pharmaceutical (Zhongshan) Inc.
- Inspection Date: 2017-10-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 920920 - 2015-03-20
- [FDA Inspection 823594 - 2012-10-31](https://www.keypedia.com/records/fda_inspections/anshi-pharmaceutical-zhongshan-inc/5ba36e06-8bcf-46e9-aef1-8c70336d0c9c)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/lindsey-s-fleischman/19ba1e93-b804-487c-8c34-68dc703b0013)

Company: https://www.keypedia.com/companies/anshi-pharmaceutical-zhongshan-inc/233f6e41-0b8b-469b-8394-d9e9f3486774

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c